Nune Makarova

Statistics

Publications

Citations

174

H-Index

Active since

2023

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

Queen Mary University of London

Barts Health NHS Trust

Brigham and Women's Hospital

Regeneron (United States)

Nune Makarova is an author at Alnylam Pharmaceuticals (United States) specializing in blood pressure control, blood pressure management, and molecular biology.

ORCID

Publications per year

2023–2025

Publications

RNA Interference With Zilebesiran for Mild to Moderate Hypertension

George L. Bakris, Manish Saxena, Anil Gupta et al. · JAMA · 2024 · 116 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension

Akshay S. Desai, Adam Karns, Jolita Badarienė et al. · JAMA · 2025 · 27 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Phase I randomized double-blind study of an RNA interference therapeutic targeting HSD17B13 for metabolic dysfunction-associated steatohepatitis

Arun J. Sanyal, Jörg Täubel, Prajakta Badri et al. · Journal of Hepatology · 2025 · 18 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Interim phase 1 part A results for ALN‐APP, the first investigational RNAi therapeutic in development for Alzheimer’s disease

Sharon Cohen, Simon Ducharme, Jared R. Brosch et al. · Alzheimer s & Dementia · 2023 · 13 citations · Full text

Medicine, Neurology, Pharmacology +17

1–4 of 4